Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT03294161Phase 2Completed
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
PrincipalinvestigatorStart date: 2014-12-01
NCT01472263Phase 3Completed
Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases
HTLV-1Immune System DiseasesPentoxifylline+2 more
Studychair

Research Network

Collaboration Network

7 collaborators·7 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Davi Costa, MD

Federal University of Bahia

Similar
1 trials

Shared therapeutic areas:

Human T-lymphotropic virus 1Immune System DiseasesPentoxifylline+2 more

Worked with same sponsors:

Hospital Universitário Professor Edgard Santos
Collaborated on 1 trial
Similarity Score54%

André Muniz Santos, MD, PhD

Federal University of Bahia

Similar
1 trials

Shared therapeutic areas:

Human T-lymphotropic virus 1Immune System DiseasesPentoxifylline+2 more

Worked with same sponsors:

Hospital Universitário Professor Edgard Santos
Collaborated on 1 trial
Similarity Score54%

Paulo RL Machado, MD, PhD

Federal University of Bahia

Moderately Similar
3 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasisLeishmaniasis; American

Worked with same sponsors:

Conselho Nacional de Desenvolvimento Científico e TecnológicoFederal University of Bahia+2 more
Collaborated on 1 trial
Similarity Score34%

Jaime Soto, MD

Fundacion Nacional de Dermatologia

Related
4 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasisLeishmaniasis; American
Similarity Score11%

Steven Jacobson, Ph.D.

National Institute of Neurological Disorders and Stroke (NINDS)

Related
6 trials

Shared therapeutic areas:

Human T-lymphotropic virus 1Paraparesis, Tropical Spastic
Similarity Score8%

Franco Piazza, MD, MPH

Access to Advanced Health Institute (AAHI)

Related
6 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasis
Similarity Score8%

Marcos López, PhD

The University of Akron

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score4%

Bart Depreitere, PhD, MD

Universitaire Ziekenhuizen KU Leuven

Related
3 trials

Shared therapeutic areas:

Physical Disability
Similarity Score4%

Thijs Swinnen, MSc, PT

Universitaire Ziekenhuizen KU Leuven

Related
2 trials

Shared therapeutic areas:

Physical Disability
Similarity Score4%

Gail Gauvreau, PhD

McMaster University

Related
12 trials

Shared therapeutic areas:

Immune System Diseases
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03294161Phase 2PrincipalInvestigator

Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis

LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
Completed
NCT01472263Phase 3StudyChair

Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases

HTLV-1Immune System DiseasesPentoxifylline+2 more
Completed

All 2 trials loaded